Advances in management of hepatocellular carcinoma

Current Opinion in Oncology
Manon Allaire, Jean-Charles Nault

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of death by cancer worldwide due to a dismal prognosis. The aim of this review is to summarize the main advances in the pathophysiology and management of HCC. Genomic analysis has recently delineated the key signaling pathways aberrantly deregulated in HCC (telomere maintenance, cell cycle gene, Wnt/β-catenin, epigenetic modifier, oxidative stress etc.). Major advances in the clinical care of patients with HCC are helping to refine the diagnosis algorithm and tumor staging. Extension of criteria for liver transplantation, but also for liver resection and percutaneous ablation, aims to increase the number of patients being treated in a curative attempt. Moreover, radioembolization is a competitor for transarterial chemoembolization in Barcelona clinic liver cancer B patients, and sorafenib in Barcelona clinic liver cancer C with tumor portal thrombosis. In advanced HCC, sorafenib is the standard of first-line care and regorafenib as a second line. New concepts on liver resection, percutaneous ablation or liver transplantation aim to extend the numbers of patients treated for HCC in curative attempts. Moreover, immunotherapy (anti death protein 1) and biotherapy adapted ...Continue Reading

References

Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Y YaoJ P Roberts
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Sep 18, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Norman M KnetemanDavid L Bigam
Mar 30, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jorge A MarreroAnna S Lok
Dec 12, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alejandro FornerJordi Bruix
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Sep 5, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gisèle N'KontchouOlivier Seror
Feb 27, 2010·Journal of Hepatology·Christine NeuveutMarie Annick Buendia
Apr 27, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Prashant BhanguiDaniel Azoulay
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
May 29, 2012·Nature Genetics·Wing-Kin SungJohn M Luk
Jul 4, 2012·Gastroenterology·Christophe DuvouxUNKNOWN Liver Transplantation French Study Group
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J JohnsonAnn-Lii Cheng
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep M LlovetJoong-Won Park
Oct 2, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann-Lii ChengEric Raymond
Jul 6, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Masatoshi KudoJian-Hua Wang
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donald G MitchellClaude B Sirlin
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Andrew X ZhuLi-Tzong Chen
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jean Charles NaultJessica Zucman-Rossi
Nov 5, 2014·Seminars in Liver Disease·Bruno Sangro, Riad Salem
Dec 3, 2014·Journal of Vascular and Interventional Radiology : JVIR·Timothy J ZiemlewiczFred T Lee
Dec 10, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Calin CainapSaied El-Nowiem
Dec 18, 2014·Surgical Endoscopy·Le XiaoShu-Guo Zheng
Dec 31, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuYoon-Koo Kang
Feb 19, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francis Y YaoJohn P Roberts
Jun 10, 2015·Nature Reviews. Clinical Oncology·Josep M LlovetRichard S Finn
Jun 24, 2015·Gastroenterology·Jessica Zucman-RossiJosep M Llovet
Aug 25, 2015·Nature Genetics·Jean-Charles NaultJessica Zucman-Rossi

❮ Previous
Next ❯

Citations

Jun 28, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Yuri L BoteonSimon C Afford
Jun 20, 2018·Drugs·Young-A Heo, Yahiya Y Syed
Oct 3, 2018·Communications Biology·Nicholas R PerkonsTerence P Gade
Sep 19, 2019·World Journal of Gastroenterology : WJG·Shi-Yi ShaoTing-Bo Liang
Jul 29, 2019·Hepatology International·Lifeng Wang, Fu-Sheng Wang
Dec 14, 2019·Biochemical and Biophysical Research Communications·Xiaokang ShiChanghua Wang
Feb 5, 2021·Journal of Cancer Research and Clinical Oncology·Cyrill WehlingMarkus Mieth
Nov 11, 2018·Molecular Genetics and Metabolism·Katell Peoc'hJean-Charles Deybach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.